Essential fatty acid treatment

Details Essential fatty acid treatment Essential fatty acid treatment

1991-05-23

1993-01-12

Michl, Paul R.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

424 45, 424434, 424435, 424436, 424451, 424456, 424463, 424464, 424489, 424499, 424427, 424437, 514560, 514826, 514861, 514825, 514886, 514887, A61K 3120, A61K 908, A61K 912, A61K 948

Patent

active

051788730

ABSTRACT:
A method of inhibiting phospholipase A2 in the control of inflammation, wherein delta-6,9,12,15-octadecatetraenoic acid (stearidonic acid) and/or delta-8,11,14,17-eicosatetraenoic acid is administered alone or in a pharmaceutically acceptable diluent or carrier.

REFERENCES:
patent: 4584320 (1986-04-01), Rubin
patent: 4681896 (1987-07-01), Horrobin
patent: 4810497 (1989-03-01), Horrobin
patent: 4843095 (1989-06-01), Rubin
patent: 4855136 (1989-08-01), Horrobin et al.
patent: 4868212 (1989-09-01), Horrobin
patent: 4898885 (1990-02-01), Horrobin
patent: 4977187 (1990-12-01), Horrobin

Affiliated with

Also associated with

Rating

Essential fatty acid treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Essential fatty acid treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Essential fatty acid treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1218378